FEDERAL COURT OF AUSTRALIA
Cytec Industries Inc. v Nalco Company [2019] FCA 1800
File number(s): NSD 130 of 2019 Judge(s): BURLEY J Date of judgment: 4 November 2019 Catchwords: PATENTS – application to amend under s 105(1A) of the Patents Act 1990 (Cth) – reducing aluminosilicate scale in the Bayer process – where amendments narrow the claims by specifying particular molecules to be used – application to amend granted Legislation: Intellectual Property Laws Amendment (Raising the Bar) Act 2012 (Cth)
Patents Act 1990 (Cth) ss 40, 60(4), 102, 104, 105(1A), 105(2), 112
Cases cited: Bristol-Myers Squibb Company v Apotex Pty Ltd (No 2) [2010] FCA 901
Cytec Industries Inc. v Nalco Company [2018] APO 4
Cytec Industries Inc. v Nalco Company [2019] APO 2
Electronic Tax-Free Shopping Ltd v Fexco Merchant Services (No 3) [2017] FCA 569
Garford Pty Ltd v Dywidag-Systems International Pty Ltd [2014] FCA 1039
Idenix Pharmaceuticals LLC v Gilead Sciences Pty Ltd (No 2) [2018] FCAFC 7
Technological Resources Pty Limited v Tettman [2018] FCA 1770
Date of hearing: 30 October 2019 Registry: New South Wales Division: General Division National Practice Area: Intellectual Property Sub-area: Patents and associated Statutes Category: Catchwords Number of paragraphs: 51 Solicitor for the Appellant: Mr P Kerr of Allens Counsel for the Respondent: Mr J S Cooke with Ms A E McDonald Solicitor for the Respondent: Shelston IP ORDERS
NSD 130 of 2019 BETWEEN: CYTEC INDUSTRIES INC.
Appellant
AND: NALCO COMPANY
Respondent
AND BETWEEN: NALCO COMPANY
Cross-Appellant
AND: CYTEC INDUSTRIES INC.
Cross-Respondent
JUDGE:
BURLEY J
DATE OF ORDER:
4 November 2019
THE COURT ORDERS THAT:
1.Pursuant to s 105(1A) of the Patents Act 1990 (Cth), the claims of Australian Patent Application No. 2012220990 be amended to take the form indicated in Annexure A to these orders.
2.The respondent pay the appellant’s costs of the respondent’s interlocutory application filed on 29 March 2019.
3.The proceedings be listed for case management on 21 November 2019.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
ANNEXURE A
THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS:-
1.A method for the reduction of aluminosilicate containing scale in a Bayer process comprising the step of:
adding to the Bayer process stream an aluminosilicate scale inhibiting amount of a composition comprising at least one small molecule
selected from the group consisting of compounds (I) through (XIII), (XV) through (XXX), (XXXII) through (XLVII), (LIII) through (LVIII) and (LX) within a product mixture formed from the reaction of a) hexane diamine, ethylene diamine or 1-amino-2-propanol; b) 3-glycidoxypropyltrimethoxysilane; and c) 2-ethylhexyl glycidyl ether:
2.A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (I) through (XIII), (XV) through (XXX) and (XXXII) through (XLII).
3.A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (LIII) through (LVIII).
4.A method according to claim 1, wherein the small molecule is selected from the group consisting of…
Keep reading for free
Create a free CaseChat account to read Cytec Industries Inc. v Nalco Company and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2019] FCA 1800
- Decision Date
CaseChat Overview and Summary
The court found that the proposed amendments did indeed narrow the scope of the claims as required by section 105(1A) of the Patents Act. The court noted that the amendments specified particular molecules to be used in the composition, thereby narrowing the scope of the claims. The court also found that the amendments did not introduce new matter, as the proposed molecules were already disclosed in the original application. The court was satisfied that the amendments were consistent with the requirements of the Act and granted the application to amend the patent claims. The court also ordered that the respondent pay the appellant’s costs of the interlocutory application and listed the proceedings for case management.
Orders
Orders of the court
1. Pursuant to s 105(1A) of the Patents Act 1990 (Cth), the claims of Australian Patent Application No. 2012220990 be amended to take the form indicated in Annexure A to these orders.
2. The respondent pay the appellant’s costs of the respondent’s interlocutory application filed on 29 March 2019.
3. The proceedings be listed for case management on 21 November 2019.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
ANNEXURE A
THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS:-
1. A method for the reduction of aluminosilicate containing scale in a Bayer process comprising the step of:
adding to the Bayer process stream an aluminosilicate scale inhibiting amount of a composition comprising at least one small molecule
selected from the group consisting of compounds (I) through (XIII), (XV) through (XXX), (XXXII) through (XLVII), (LIII) through (LVIII) and (LX) within a product mixture formed from the reaction of a) hexane diamine, ethylene diamine or 1-amino-2-propanol; b) 3-glycidoxypropyltrimethoxysilane; and c) 2-ethylhexyl glycidyl ether:
2. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (I) through (XIII), (XV) through (XXX) and (XXXII) through (XLII).
3. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (LIII) through (LVIII).
4. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (LIII), (LIV) and (LV).
5. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (I) through (IX).
6. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (X) through (XIII) and (XV) through (XIX).
7. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (XX) through (XXII).
8. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (XXIII) through (XXIX).
9. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (XXX) and (XXXII).
10. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (XXXIII) though (XLII).
11. A method according to claim 1, wherein the small molecule is selected from the group consisting of compounds (LVI) through (LVIII) and (LX).
12. A method according to claim 1, wherein the small molecule is present in a solution in an amount ranging from about 0.01 to about 100 wt%.
13. A method according to claim 1, wherein the composition further comprises an item selected from the list consisting of: amines, activators, antifoaming agents, co-absorbents, corrosion inhibitors, coloring agents, and any combination thereof.
14. A method according to claim 1, wherein the composition comprises a solvent, the solvent is selected from the group consisting of: water, alcohols, polyols, other industrial solvents, organic solvents, and any combination thereof.
15. A method according to claim 1, wherein the composition is isolated from a synthesis reaction in the form of a solid, precipitate, gel, salt and/or crystalline material in pHs ranging from 0 to 14.
16. A method according to claim 1, wherein the composition is hydrolyzed prior to being added to the Bayer process.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.